6-Hydroxytryptophan Synthesis via Chiral Hydrogenation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for synthesizing (S)-6-hydroxytryptophan and its derivatives, such as (S)-6-Acetyloxy-N-tert-butoxycarbonyl-tryptophan, lack efficiency, reproducibility, and enantiomeric purity, which are crucial for the large-scale production of amanitins and amatoxin-based antibody-drug conjugates.
Innovation Solution
An enantiomer-selective hydrogenation method using chiral catalysts like HDP 30.2758, (R,R)-Et-DUPHOS (BF4-), (R,R)-DuPhos-Ferrocene (BF4-), (R,R)-DuPhos-Et2 (BF4-), and (R,R)-Phenyl-DuPhos-Alkyl (BF4-) for olefinic amino acid precursors to achieve high enantiomeric purity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If conventional methods using indoleacetic acid or indoleacetonitrile are used as starting materials, then L-tryptophan can be produced, but the production cost is high and racemization occurs during synthesis
Solution Approach 1:
The patent changes the chemical parameters by using a different starting material (S)-1-(3,4-dimethoxyphenyl)ethylamine instead of conventional indoleacetic acid or indoleacetonitrile, and employs specific reaction conditions including borane-dimethyl sulfide complex reduction and controlled alkylation to achieve high optical purity while reducing production costs
Solution Approach 2:
The patent employs readily available and cost-effective reagents such as borane-dimethyl sulfide complex and sodium hydride, replacing expensive conventional starting materials. The method uses simple, inexpensive chemical compounds that can be easily obtained, thereby reducing overall production costs while maintaining high stereoselectivity
2Manufacturing precision
If protection and deprotection steps are included in the synthesis process, then the reaction can proceed with high selectivity, but the number of steps increases and productivity decreases
Solution Approach 1:
The patent extracts or removes the need for protection and deprotection steps from the synthetic pathway. By carefully selecting reaction conditions and reagents, the method allows direct transformation of the starting material to the final product without requiring temporary protective groups, thereby reducing the number of synthetic steps while maintaining high selectivity
Solution Approach 2:
The patent achieves continuous useful action by eliminating interruptive protection and deprotection steps. The synthesis proceeds in a more continuous manner with fewer interruptions, allowing the reaction to flow smoothly from starting material to final product, thereby improving overall productivity and synthesis efficiency
3Manufacturing precision
If existing asymmetric synthesis methods are used, then optical purity can be achieved, but the synthesis requires excessive steps and is not economical
Solution Approach 1:
The patent segments the synthesis into a small number of highly efficient steps: (1) reductive amination to form the amine, (2) N-alkylation to introduce the side chain, and (3) demethylation to reveal the phenolic group. This segmentation into few critical steps achieves high optical purity while minimizing synthetic complexity and improving economy
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method provides a simple, efficient, and reproducible synthesis of (S)-6-hydroxytryptophan and its derivatives with enantiomeric purities exceeding 98%, reducing costs and enhancing the production of amanitins and amatoxin-based therapeutic agents.
Implementation Method 1
The imine obtained in step 1 was treated with borane-dimethyl sulfide complex in dimethyl sulfoxide at 70° C. for 1 hour to give (s)-1-(3,4-dimethoxyphenyl)ethylamine
Data Source
Figure 1
Figure 2
Figure 3
AI summary
The present invention relates to novel methods and compounds for synthesizing amanitin derivatives. The invention in particular relates to methods for synthesizing (S)-6-hydroxy-tryptophan derivatives which can be used as building blocks for synthesizing amanitin derivatives or amatoxin drug conjugates. The invention further relates to intermediate compounds of said synthesis pathways for use in amanitin derivative and amatoxin drug conjugate synthesis, and to the use of particular catalysts suited for mediating said synthesis pathways.